Metraipolis › archive › dc_362dc8e30826

Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network — Europe PMC PMID:42346225

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346225
DOI
10.3390/curroncol33060325
License (as archived)
solo-consultazione
Archived
2026-11-01T03:17:52.339Z
SHA-256 of the archived text
70cff0a698635d35fd6f7d861de6e4bc692b6be8bc22ee84bf34fd87620b384a
Stable URL of this page
https://metraipolis.com/documento/dc_362dc8e30826

How to cite

Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network — Europe PMC PMID:42346225 — Europe PMC (en), https://europepmc.org/article/MED/42346225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_362dc8e30826 (Metraipolis archive dc_362dc8e30826, sha256 70cff0a698635d35fd6f7d861de6e4bc692b6be8bc22ee84bf34fd87620b384a)
BibTeX
@misc{dc362dc8e30826,
  title = {Real-World Analysis of Metastatic Renal Cell Carcinoma Patients Treated with Pembrolizumab Plus Axitinib: Evidence from the Campania Oncology Network — Europe PMC PMID:42346225},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346225},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_362dc8e30826; sha256 70cff0a698635d35fd6f7d861de6e4bc692b6be8bc22ee84bf34fd87620b384a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346225. Agents can read the archived copy with the MCP tool read_document.